NICE has recommended routine NHS access to nusinersen and risdiplam for spinal muscular atrophy, ending time-limited managed access schemes in place since 2019.
United Kingdom (National)
Sheena Meredith
Geo Focus
Coverage Attributes:
Beta
Informative:
43
%
Data Driven:
38
%
Cites Data:
8
%
Press Release:
2
%
Government Announcement:
1
%
Themes Covered:
Not enough data
Pitching Insights
Sheena Meredith's coverage predominantly focuses on healthcare, medical research, disease prevention, and medical treatments. Her articles heavily cite data to support the information presented.
If you are reaching out to Sheena with a pitch or as a potential source, consider providing fact-based insights supported by credible data in the field of healthcare and medicine. This could include new medical research findings, innovative approaches to disease prevention or treatment backed by strong evidence, or analysis of health trends that have statistical backing.
Given Sheena's national focus on the United Kingdom, pitches related to developments specific to UK healthcare regulations, policies or advancements would likely be particularly relevant for her audience.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Journalists With Similar Coverage:
Based on similarity of content.
Publications
Most recent topics
Not enough data
Publications
Most recent topics
Not enough data
Publications
Most recent topics
Not enough data
